Centene Corporation (NYSE:CNC) is one of the best affordable stocks to buy with good earnings growth. JPMorgan cut the price target on Centene Corporation (NYSE:CNC) to $41 from $45 on March 19, reiterating a Neutral rating on the shares. The firm considers the stock’s 16% selloff in the past week as a reminder that Managed Medicaid “remains the subsection of managed care (and perhaps healthcare services) with the widest error bars in 2026.” JPMorgan cut the stock’s estimates to take into account near-term ...

Core Insights - Sunshine Health, a subsidiary of Centene Corporation, has awarded $100,000 in grants to support childcare and transportation for vulnerable populations in Florida [1][2]. Group 1: Grant Details - The grants were distributed to five nonprofit organizations across more than 40 counties in Florida, aimed at reducing barriers to employment [1][2]. - The organizations receiving the grants include: - Wheels of Success: Provides vehicles or major car repairs for individuals working or attending school in Hillsborough, Pasco, and Pinellas counties [2][3]. - Van Gogh's Palette (dba Vincent House): Offers transportation for job interviews and employment participation in Pasco, Pinellas, and Hernando counties [3]. - Boys and Girls Club of North Central Florida: Delivers no-cost childcare programs in Taylor County [3]. - Safe Families for Children Alliance: Assists with childcare registration and transportation across 37 counties [3]. - Healthy Start Coalition of St. Lucie: Provides transportation assistance for families in St. Lucie County [4]. Group 2: Impact and Statements - Sunshine Health's President and CEO, Charlene Zein, emphasized the importance of partnerships with nonprofits to create sustainable solutions for families [2]. - Emily Ketring, Executive Director of Boys & Girls Club of North Central Florida, highlighted that the grant will help address childcare barriers affecting workforce participation in rural communities [5]. - Susan Jacobs, Founder and CEO of Wheels of Success, noted that reliable transportation is crucial for young adults aging out of foster care to secure employment and education [6]. Group 3: Company Overview - Sunshine Health is one of the largest healthcare plans in Florida, providing managed care through various programs including Medicaid and Medicare Advantage [6]. - The company focuses on coordinated care and community health transformation, serving diverse populations with specialized plans for children and individuals with specific health needs [6].

Financial Data and Key Metrics Changes - For 2025, the company reported an Adjusted EBITDA loss of $161.3 million, with a normalized Adjusted EBITDA loss of $149.1 million, reflecting a $44 million improvement over 2024 [14][17] - Total revenue for Q4 2025 was $384.8 million, up from $370.7 million in Q4 2024, while full-year revenue was $1.46 billion, down from $1.50 billion in 2024 [14][15] - Capitated revenue per member per month (PMPM) improved by 9% to $1,060 in Q4 2025 and by 5% to $1,026 for the full year [14][15] Business Line Data and Key Metrics Changes - The medical margin for Q4 2025 was -$28.7 million, compared to $7.3 million in Q4 2024, while the full-year medical margin was $23.5 million, down from $85.4 million in 2024 [15][16] - The company achieved Four-Star status across 70% of its priority Medicare Advantage plans, indicating improved quality performance [8] Market Data and Key Metrics Changes - The company announced a partnership that expands its presence into a new Medicare Advantage geography, adding 29,000 new members, which represents a 25% year-over-year growth [9] - Total lives under management in 2026 are expected to reach approximately 140,000 members, contributing roughly $27 million in revenue [9] Company Strategy and Development Direction - The company is focused on smart growth, entering new geographies through a phased glide path to risk, which allows for operational execution before assuming full risk [9][10] - Structural and operational improvement opportunities totaling $170 million have been identified, with 75% expected from contracting and revenue-related actions [6][7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a midpoint Adjusted EBITDA of $10 million for 2026, representing a significant improvement from 2025 [5][18] - The company aims to continue improving its cost structure while targeting investments in frontline operations to support clinical performance and medical cost stability [20] Other Important Information - The company ended 2025 with $25 million in cash and is focused on disciplined working capital management [18] - The company has made strides in improving its underlying cost structure and is committed to maintaining a disciplined operating approach [20] Q&A Session Summary Question: Are the 29,000 lives from the Nebraska agreement included in the risk member guidance midpoint of 112,000? - The 29,000 lives are additional and not included in the 112,000 full risk members [25] Question: What kind of standup costs or geo-entry costs are needed for the new geography? - The deal's economics allow for funding to cover stand-up costs, utilizing existing infrastructure [26] Question: How much of the $170 million improvement is run-rated entering the year versus what still needs to be activated in 2026? - About 75% of the $170 million is run-rated starting in January, focusing on revenue and contract updates [28] Question: How will the company interact with the Nebraska plan for the first two years? - There is a two-year glide path to risk, with a contractually set transition to full risk in 2028 [35][36] Question: What tangible examples differentiate the 2026 contracts from 2025? - Changes include adjustments in premium amounts and charges, as well as improvements in Stars performance impacting plan revenue [38][39]

Core Insights - P3 Health Partners Inc. reported its financial results for Q4 and full year 2025, indicating a strategic repositioning of the business and a clear path to profitability for 2026 with an expected $10 million adjusted EBITDA midpoint [1][2]. Financial Performance Fourth Quarter 2025 Results - Total revenue reached $384.8 million, up from $370.7 million in Q4 2024, with capitated revenue PMPM improving by 9% year-over-year to $1,060 [3]. - The company reported a net loss of $165.7 million compared to a net loss of $129.1 million in the same quarter of the previous year [3]. - Adjusted EBITDA loss was $76.1 million, worsening from a loss of $67.6 million in Q4 2024 [3]. Full-Year 2025 Results - Total revenue for the year was $1.46 billion, down from $1.50 billion in 2024, with capitated revenue PMPM improving by 5% year-over-year to $1,026 [3]. - The net loss for the year was $323.1 million, compared to a net loss of $310.4 million in 2024 [3]. - Adjusted EBITDA loss for the year was $161.3 million, an improvement from a loss of $167.2 million in 2024 [4]. 2026 Guidance - The company expects adjusted EBITDA to range from negative $20 million to positive $40 million, with a midpoint of $10 million, indicating a projected $170 million year-over-year improvement [4]. - At-risk membership is anticipated to be between 107,000 and 117,000, with total revenues expected to be between $1.5 billion and $1.7 billion [4]. Strategic Initiatives - The CEO highlighted the strengthening of contract economics and provider alignment as key factors in the company's progress, emphasizing a deliberate approach to growth that enhances long-term earnings potential [2]. - The company aims to improve its operational foundation and provider relationships to support its transition to profitability [2].

Market Overview - The Dow Jones Industrial Average increased by 356.75 points (0.77%) to reach 46,480.81, driven by optimistic economic data and moderating inflation [1] - Dow Futures also rose by 359.00 points (0.77%), indicating sustained market confidence [1] Sector Performance - Merck & Co., Inc. (MRK) led the gainers with a rise of 2.59% to $119.43, supported by strong pharmaceutical performance and positive clinical trial updates [2] - Amazon.com, Inc. (AMZN) increased by 2.39% to $212.21, while Honeywell International Inc. (HON) rose by 2.34% to $226.77 [2] - Johnson & Johnson (JNJ) and Amgen Inc. (AMGN) also performed well, with increases of 2.28% to $240.78 and 1.80% to $354.85, respectively [2] - In the tech sector, Nvidia (NVDA) rose by 2.16% to $179.00, and The Boeing Company (BA) increased by 1.75% to $199.94 due to improved production efficiency [2] Decliners - UnitedHealth Group Incorporated (UNH) saw a decline of 1.14% to $269.16, attributed to a rotation out of managed care providers [3] - NIKE, Inc. (NKE) fell by 0.76% to $53.11 due to a cautious outlook on global consumer spending [3] - Other decliners included Salesforce, Inc. (CRM) down 0.73% to $181.86 and Verizon Communications Inc. (VZ) down 0.62% to $50.60 [3]

Core Insights - UnitedHealth Group Incorporated (UNH) and Centene Corporation (CNC) are key players in the healthcare industry, benefiting from increasing healthcare demand, an aging population, and a rise in chronic diseases [1] - UnitedHealth is in a strong leadership position with steady execution, while Centene is undergoing a turnaround focused on efficiency and margin recovery [2] UnitedHealth Overview - UnitedHealth has a market cap of $250.1 billion and operates with a dual-engine model, combining insurance through UnitedHealthcare and technology-enabled health services via Optum [4] - The company reported a 12% revenue growth in its latest quarter, driven by growth in commercial fee-based membership and Optum Rx [5] - Despite the revenue growth, adjusted earnings fell by 69% year over year due to high medical costs and a decline in risk-based membership [5] - UnitedHealth's profitability is supported by its scale, data integration, and care delivery capabilities, with estimated operating cash flows of $18 billion in 2026 [6] - The company plans to repurchase $2.5 billion in shares and pay $8 billion in dividends [6] Centene Overview - Centene has a market cap of $16.9 billion and focuses heavily on government-sponsored programs, particularly Medicaid, which exposes it to policy changes [8] - In its most recent quarter, Centene's revenues increased by 21.9% year over year, but it reported a loss of $1.19 per share compared to earnings of 80 cents per share a year ago [9] - The company is working on margin recovery by exiting underperforming markets and repricing contracts, but faces structural challenges [9] - Centene's return on invested capital is 3.76%, lower than UnitedHealth's 5.37% [9] Financial Comparisons - UnitedHealth's margins and cash flow are stronger compared to Centene, which has higher risk and is in a turnaround phase [10] - Centene's medical loss ratio (HBR) is projected to be between 90.9% and 91.7% for 2026, while UnitedHealth expects a medical cost ratio (MCR) of 88.8% [11] - Centene's long-term debt-to-capital ratio is 46.45%, higher than UnitedHealth's 42.48%, indicating greater financial leverage [12] Earnings Estimates - For UnitedHealth, the Zacks Consensus Estimate forecasts 2026 EPS of $17.70, reflecting an 8.3% year-over-year growth [13] - Centene's 2026 earnings estimate stands at $3.05 per share, implying a 46.6% year-over-year growth as cost pressures ease [14] Valuation and Price Performance - UnitedHealth trades at a forward P/E of 15.17X, while Centene trades at 10.51X, reflecting UnitedHealth's superior earnings visibility and lower risk [15] - Over the past month, UnitedHealth's shares gained 0.6%, outperforming Centene and the broader market [17] - UnitedHealth's average price target suggests a 28.1% upside, while Centene's indicates a 23.7% upside [20] Conclusion - Both companies are positioned to benefit from long-term healthcare trends, but UnitedHealth offers greater stability and a more consistent growth trajectory compared to Centene's uncertain outlook [21][22]

Core Viewpoint - P3 Health Partners Inc. is set to release its financial results for the fourth quarter and full year 2025 on March 26, 2026, with a conference call scheduled to discuss these results [1] Financial Results Announcement - The financial results for the fourth quarter and full year 2025 will be released on March 26, 2026 [1] - A conference call will be held at 1:30 PM PT / 4:30 PM ET on the same day to discuss the results [1] - The press release will be available on the Investor page of P3's website prior to the conference call [1] Company Overview - P3 Health Partners Inc. is a leading population health management company focused on improving healthcare for patients and providers [1] - The company has over 2,800 affiliated primary care providers across the United States [1] - P3 operates in 24 counties across four states, providing value-based care coordination and administrative services [1] Recent Developments - P3 Health Partners has formed a Joint Venture Management Services Organization with Commonwealth Primary Care ACO to enhance support for primary care physicians in multiple states [1]

Group 1 - Molina Healthcare, Inc. is identified as a long-term loser in the S&P 500, with significant exposure to Medicare and Medicaid, which are considered weak segments of the business [1] - The stock has declined by 63% over the past two years, indicating a substantial drop in market value [1] - The company provides managed health services for low-income individuals and families through federal and state programs, and has no exposure to tariffs, which contributed to a 4% stock rally on a specific day [2] Group 2 - The stock is down nearly 55% since the time of the previous comments, suggesting ongoing challenges for the company [3] - While there is potential for Molina Healthcare as an investment, certain AI stocks are viewed as having greater upside potential and less downside risk [3]

Core Insights - Superior HealthPlan has designated Cute Pediatrics as the first Foster Care Center of Excellence in the Rio Grande Valley, making it the 14th provider in Texas to receive this distinction [1][1][1] Group 1: Company Overview - Superior HealthPlan is a leading managed care organization in Texas and a subsidiary of Centene Corporation, serving approximately 2 million people [1][1] - The company has been providing high-quality healthcare for over 25 years and has 3,600 employees across all 254 Texas counties [1][1] Group 2: Foster Care Center of Excellence Program - The Foster Care Center of Excellence program was launched in 2017 to enhance the care for foster care members in the STAR Health Medicaid program [1][1] - Providers must meet over 30 criteria, including quality improvement initiatives and staff requirements, to qualify for this designation [1][1] Group 3: Cute Pediatrics - Cute Pediatrics offers comprehensive pediatric care for children from newborns to 21 years of age, with locations in Brownsville and Harlingen [1][1] - The clinic emphasizes a family-centered approach and provides bilingual services to support Spanish-speaking families [1][1]

Summary of UnitedHealth Group FY Conference Call (March 10, 2026) Company Overview - **Company**: UnitedHealth Group (NYSE: UNH) - **Event**: Barclays Global Healthcare Conference Key Points Financial Performance and Growth Expectations - UnitedHealth Group is guiding for over **8.5% growth** for the year, indicating a prudent and conservative approach to expectations [5][6] - Early performance in 2026 is encouraging, aligning with expectations set in January [5] Medicare Segment Insights - Medical cost trend increased from **7.5% in 2025** to **10% in 2026**, driven by known rate elements and unknown risk factors [7][9] - Core utilization is assumed to remain constant, with a significant portion of the increase attributed to the return of the physician fee schedule and inpatient rates [9][12] - Concerns were raised regarding the **2027 Medicare Advance Notice** and the recalibration of the risk model, particularly the weighting of skin substitutes over chronic conditions [14][18] Medicaid Segment Outlook - Expectations for Medicaid margins are projected to decline by **100-170 basis points** [28] - Rate negotiations are ongoing, with anticipated increases of **6%-7%** effective July 1 [28][29] - There is a noted disconnect between actual trends and the rates being pursued [31] Individual ACA Exchanges - Membership in ACA exchanges is expected to decline by over **500,000**, with disenrollment trends tracking as anticipated [32][34] Optum Health Performance - Optum Health underperformed guidance by approximately **$600 million** in Q4, with **70%** of this attributed to one-time items [35][36] - A **$620 million** provision for expected 2026 contract losses is related to external contracts, which may provide a tailwind for 2027 [38][39] - Long-term margin targets remain confident, with pathways identified to achieve **6%-8%** margins through integrated value-based care and diverse business segments [42][43] AI and Technology Investments - UnitedHealth is investing **$1.5 billion** in AI, with expectations for significant cost efficiencies and productivity improvements [52][53] - The company anticipates that AI will enhance operational efficiency, potentially leading to a significant impact on the G&A ratio in the coming years [55][59] Legislative Environment and Optum Rx - Optum Rx is well-positioned to handle recent PBM reforms, having already implemented **100% commercial rebate pass-through** [61][62] - The business is experiencing strong momentum, with record sales and a focus on transparency and integrated solutions [61] Capital Deployment and M&A Strategy - UnitedHealth expects to generate at least **$18 billion** in free cash flow, with plans to maintain and grow dividends [63] - The company is committed to reducing its debt-to-capital ratio to **40%** and will be active in share buybacks and M&A, particularly if market conditions remain favorable [64][65] Strategic Focus - The company emphasizes the importance of Optum Insight and Optum Health in its future strategy, with a strong belief in the value-based care model [65][66] Additional Insights - The dialogue with CMS regarding the recalibration of risk models is ongoing, with UnitedHealth providing data-driven feedback [23][24] - The company is focused on ensuring that technology-driven effects are accurately reflected in future forecasts [25][26] This summary encapsulates the key insights and strategic directions discussed during the conference call, highlighting UnitedHealth Group's performance, challenges, and future outlook in the healthcare sector.